This interview examines the use of KIR genotyping during donor selection and its association with improved outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation.
Katy Rezvani, MD, PhD
Advertisement
Articles by Katy Rezvani, MD, PhD
Advertisement
Latest Updated Articles
Using KIR Genotyping to Improve Transplant SuccessJanuary 5th 2017
Advertisement
Advertisement
Trending on CancerNetwork
1
Atirmociclib/Fulvestrant Improves PFS in HR+/HER2– Breast Cancer
2
FDA Approves Companion Diagnostic for Niraparib in Advanced Ovarian Cancer
3
NCCN Guidelines Add Novel Therapeutics to First-Line TNBC Armamentarium
4
Novel Immunotherapy Reduces Breast Recurrence Rates in Non-HLA-A*02 Population
5